Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Citi
Daiichi Sankyo
Covington
AstraZeneca
Accenture
Deloitte
Baxter
Mallinckrodt

Generated: December 14, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GADOBENATE DIMEGLUMINE

« Back to Dashboard

Clinical Trials for Gadobenate Dimeglumine

Trial ID Title Status Sponsor Phase Summary
NCT00323310 Safety and Efficacy of MultiHance in Pediatric Patients Terminated Bracco Diagnostics, Inc Phase 3 The purpose of this study was to assess the safety and enhancing properties of the magnetic resonance imaging (MRI) contrast agent MultiHance in children aged 2 to 17 years having central nervous system (CNS) disorders.
NCT01165892 Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar) Completed Lantheus Medical Imaging N/A The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI).
NCT01165892 Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar) Completed Washington University School of Medicine N/A The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI).
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Gadobenate Dimeglumine

Condition Name

Condition Name for Gadobenate Dimeglumine
Intervention Trials
Adult Supratentorial Primitive Neuroectodermal Tumor 1
Adult Ependymoblastoma 1
Central Nervous System Neoplasms 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Gadobenate Dimeglumine
Intervention Trials
Nervous System Diseases 2
Central Nervous System Diseases 2
Pulmonary Embolism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Gadobenate Dimeglumine

Trials by Country

Trials by Country for Gadobenate Dimeglumine
Location Trials
United States 6
China 1
Hungary 1
Mexico 1
Czech Republic 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Gadobenate Dimeglumine
Location Trials
California 2
Michigan 2
Wisconsin 1
New Jersey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Gadobenate Dimeglumine

Clinical Trial Phase

Clinical Trial Phase for Gadobenate Dimeglumine
Clinical Trial Phase Trials
Phase 3 2
Phase 2 3
N/A 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Gadobenate Dimeglumine
Clinical Trial Phase Trials
Completed 3
Recruiting 2
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Gadobenate Dimeglumine

Sponsor Name

Sponsor Name for Gadobenate Dimeglumine
Sponsor Trials
Bracco Diagnostics, Inc 3
National Cancer Institute (NCI) 2
University of Michigan 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Gadobenate Dimeglumine
Sponsor Trials
Other 5
Industry 5
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Farmers Insurance
Cipla
Queensland Health
Citi
Express Scripts
Moodys
Healthtrust
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.